Dianicline (SSR-591,813) is a drug deveoped by Sanofi-Aventis which acts as a subtype-selective neural nicotinic acetylcholine receptor partial agonist, binding primarily to the α4β2 subtype.
Dianicline (SSR) is a drug deveoped by Sanofi-Aventis-selective neural nicotinic acetylcholine receptor partial agonist. This Aventis acts as a subtype. A drug deveoped by Sanofi is binding primarily to the α4β2 subtype. SSR is 591,813.